Waning efficacy in a long-term AAV-mediated gene therapy study in the murine model of Krabbe disease is a research paper published in Molecular Therapy (2021). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: F30NS090684
National Institutes of Health
Grant: R01 NS065808
NIA NIH HHS
Grant: R01 AG061114
NINDS NIH HHS
Grant: R01 NS100779
National Institutes of Health
Grant: 5R01NS065808-03
Combined neuroprotection and metabolic correction to treat leukodystrophies
National Institutes of Health
Grant: 5F30NS090684-02
Pathogenic mechanisms affecting the dopaminergic system in Krabbe disease
Legacy of Angels Foundation
National Institutes of Health
Association Européenne contre les Leucodystrophies
FWCI
3.54
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals